Director, Business Development & Partnership -South Korea
Quotient Therapeutics
This listing was originally posted on Quotient Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moTHE ROLE:
Flagship's Korean subsidiary is focused on bridging Flagship’s innovative ecosystem with the Korean biotech, pharmaceutical and biomedical ecosystem to fostering strategic partnerships in one of the world’s critical healthcare markets. We are seeking an accomplished and dynamic individual to join our Flagship APAC team as the Director, Alliances and Partnerships for Flagship Pioneering Korea. Reporting into the Flagship APAC organization, the successful candidate will be responsible for spearheading strategic initiatives, fostering and managing partnerships, and driving business growth in the Korean market. This role requires a visionary leader with a deep understanding of the life sciences industry, exceptional strategic thinking skills, and the ability to build and maintain high-level relationships.
KEY RESPONSIBILITIES:
PROFESSIONAL EXPERIENCE & QUALIFICATIONS:
LOCATION: Seoul, South Korea
ABOUT FLAGSHIP PIONEERING:
Flagship Pioneering invents and builds platform companies, each with the potential for multiple products that transform human health, sustainability and beyond. Since its launch in 2000, Flagship has originated more than 100 companies. Many of these companies have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.
Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
At Flagship, we accept impossible missions to enable bigger leaps. Our core values guide us through uncertainty and toward lasting impact.
We are an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, protected veteran status, or any other characteristic protected by law.
We recognize that great candidates often bring unique strengths without fulfilling every qualification. If you have some of the experience listed above but not all, please apply anyway. We are dedicated to building diverse and inclusive teams and look forward to learning more about your background and interest in Flagship.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
#LI-JR3
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Quotient Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Genetic Library
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/mo